Title:
IMPLANTABLE ACCESS DEVICE AND FLUID CIRCULATION SYSTEM
Document Type and Number:
WIPO Patent Application WO/2024/007921
Kind Code:
A1
Abstract:
Disclosed herein are an implantable access device and a fluid circulation system. The implantable access device comprises: a first access port comprising a self-sealing component that allows the entrance of a needle for extracting or injecting a fluid during the treatment; and a first communication component and a second communication component that are separately communicated with the first access port and are configured for providing a fluid circulation path for a fluid inward or outward from the first access port. Depending on the characteristic attributes of the first communication component and the second communication component, the flow resistance in the first communication component is greater than the flow resistance in the second communication component.
Inventors:
LI XIANGHAI (CN)
Application Number:
PCT/CN2023/103427
Publication Date:
January 11, 2024
Filing Date:
June 28, 2023
Export Citation:
Assignee:
SHANGHAI XINGUANG BIO PHARMACEUTICAL LTD (CN)
International Classes:
A61M1/38; A61M1/14; A61M1/36; A61M39/00
Foreign References:
| US20070123811A1 | 2007-05-31 | |||
| US20110009946A1 | 2011-01-13 | |||
| US20050033217A1 | 2005-02-10 | |||
| US20060064159A1 | 2006-03-23 | |||
| US20090234431A1 | 2009-09-17 | |||
| US20130274648A1 | 2013-10-17 | |||
| US20180280605A1 | 2018-10-04 |
Attorney, Agent or Firm:
SHANGHAI DELIDA PARTNERS, P.C. (CN)
Download PDF: